COLLECTAR BIOSCIENCES 13D

Company

Cellectar Biosciences, Inc.

Filed

September 9, 2014

Accession Number

0001044321-14-000097

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →